Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription Articles published in Diabetes Retrieve available abstracts of 237 articles: HTML format

Single Articles

October 2025
1. KELLER F, Schunk S, Denicolo S, Sharifli S, et al
   Dickkopf-3 (DKK3) and the Progression of Diabetic Kidney Disease in Primary Health Care.
   Diabetes. 2025 Oct 10:db250235. doi: 10.2337/db25-0235.
   PubMed     Abstract available
   
   
   
2. WANG X, Wan J, Wang C, Tong Y, et al
   Trem2+ Macrophages Alleviate Renal Tubule Lipid Accumulation and Ferroptosis in Diabetic Nephropathy by Repressing IL-1beta-Mediated CD36 Expression.
   Diabetes. 2025 Oct 3:db250282. doi: 10.2337/db25-0282.
   PubMed     Abstract available
   
   
   
3. PAGE B
   Diabetes Spotlight: Rebecca Anne Haeusler, PhD-Investigating Metabolism Through Insulin Signaling.
   Diabetes. 2025;74:1709.
   PubMed    
   
   
   
4. HU X, Guo L, Pilar Toledo M, Sandoval Sanchez P, et al
   Molecular Mechanisms of Human Pancreatic Islet Dysfunction Under Overnutrition Metabolic Stress.
   Diabetes. 2025;74:1825-1838.
   PubMed     Abstract available
   
   
   
5. JIA RY, Chen JH, Lockhart S, Lam BYH, et al
   Bidirectional Mendelian Randomization Indicates Causal Relationships Between Circulating Branched-Chain Amino Acids and Metabolic Health.
   Diabetes. 2025;74:1863-1872.
   PubMed     Abstract available
   
   
   
6. PEARSON ER, Del Prato S, Pavo I, Franco DR, et al
   Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4.
   Diabetes. 2025;74:1850-1862.
   PubMed     Abstract available
   
   
   September 2025
7. RAGHAVAN S, Litkowski E, Jensen A, Charest B, et al
   Genome-Wide Association Study of Hypoglycemia in Adults With Diabetes in the Million Veteran Program.
   Diabetes. 2025 Sep 19:db250304. doi: 10.2337/db25-0304.
   PubMed     Abstract available
   
   
   
8. CARTER RD, Purnama U, Castro-Guarda M, Montes-Aparicio CN, et al
   Systems Biology and Functional Assessments of Human iPSC-Cardiomyocyte Models of Insulin Resistance Capture Key Hallmarks of Diabetic Cardiomyopathy.
   Diabetes. 2025 Sep 16:db250204. doi: 10.2337/db25-0204.
   PubMed     Abstract available
   
   
   
9. LI W, Cheng Y, Cui A, Huang M, et al
   Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes.
   Diabetes. 2025 Sep 12:db250354. doi: 10.2337/db25-0354.
   PubMed     Abstract available
   
   
   
10. FLAMMER ER, Christopher MW, Powers ER, Broncucia H, et al
    Serum Metabolomics Reveals Potential Differences in Gut Microbiota-Associated Metabolites in Twins Discordant for Type 1 Diabetes.
    Diabetes. 2025 Sep 11:db250156. doi: 10.2337/db25-0156.
    PubMed     Abstract available
    
    
    
11. DING Y, Zhou Q, Jiang Y, Cao Q, et al
    Heterogeneity in Phenotype and Early Metabolic Response to Lifestyle Interventions in Type 2 Diabetes in China Using a Tree-Like Representation.
    Diabetes. 2025 Sep 4:db250197. doi: 10.2337/db25-0197.
    PubMed     Abstract available
    
    
    
12. PANG P, Liu Y, Song H, Ye Z, et al
    Application of Dental Pulp Stem Cell-Derived Intracellular Vesicles for Diabetic Wound Healing.
    Diabetes. 2025 Sep 4:db240686. doi: 10.2337/db24-0686.
    PubMed     Abstract available
    
    
    
13. DE KLERK JA, Slieker RC, Parker WC, Wu H, et al
    Cell Type-Specific Expression of Long Noncoding RNAs in Human Diabetic Kidneys Identifies TARID as a Key Regulator of Podocyte Function.
    Diabetes. 2025 Sep 3:db250272. doi: 10.2337/db25-0272.
    PubMed     Abstract available
    
    
    
14. GILLESPIE KM
    Islet Autoantibody Testing as Type 1 Diabetes Early Detection Enters Mainstream Health Care.
    Diabetes. 2025;74:1466-1468.
    PubMed    
    
    
    
15. PAGE B
    Diabetes Spotlight: David J. Hodson, BVSc, PhD, FRCVS-Regulation of Insulin and Glucagon in Pancreatic Islet Biology.
    Diabetes. 2025;74:1443-1444.
    PubMed    
    
    
    
16. ASSAF J, Khurana I, Abou Zaki R, Tam CHT, et al
    DNA Methylation Biomarkers Predict Offspring Metabolic Risk From Mothers With Hyperglycemia in Pregnancy.
    Diabetes. 2025;74:1695-1707.
    PubMed     Abstract available
    
    
    
17. ABDELGANI S, Khattab A, Adams JM, Al-Mulla F, et al
    Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate: A Randomized Trial.
    Diabetes. 2025;74:1480-1488.
    PubMed     Abstract available
    
    
    
18. ZHOU M, Yang X, Ge X, Chen J, et al
    Reducing PTP1B in the Hippocampus Protects Against Cognitive Decline in Prediabetes.
    Diabetes. 2025;74:1499-1511.
    PubMed     Abstract available
    
    
    
19. OSIPOVICH AB, Dickerson MT, Cartailler JP, Shrestha S, et al
    Dynamic Ca2+-Dependent Transcription Links Metabolic Stress to Impaired beta-Cell Identity.
    Diabetes. 2025;74:1547-1561.
    PubMed     Abstract available
    
    
    August 2025
20. SIMS EK, Russell WE, Cuthbertson D, Skyler JS, et al
    Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval.
    Diabetes. 2025 Aug 28:db250310. doi: 10.2337/db25-0310.
    PubMed     Abstract available
    
    
    
21. FAGBEMI K, Avocegamou R, Yazdanpanah N, Yazdanpanah M, et al
    Metabolome-Wide Mendelian Randomization and Observational Study Reveal Causal Links Between Circulating Metabolites and Youth-Onset Type 2 Diabetes.
    Diabetes. 2025 Aug 27:db250093. doi: 10.2337/db25-0093.
    PubMed     Abstract available
    
    
    
22. WEISS ME, Patel MJ, Watts BH, Parrales PE, et al
    Investigating Late-Stage Diabetic Retinopathy: A Long-term Analysis of Vascular Changes in the Streptozotocin-Induced Mouse Model.
    Diabetes. 2025 Aug 21:db250434. doi: 10.2337/db25-0434.
    PubMed     Abstract available
    
    
    
23. REYNOLDS KM, Sun Q, Zhang Y, Umans J, et al
    Diabetes Genetic Clusters and Clinical Outcomes in American Indians.
    Diabetes. 2025 Aug 18:db250322. doi: 10.2337/db25-0322.
    PubMed     Abstract available
    
    
    
24. ZHANG Y, Dai L, Wang M, Zhong X, et al
    Activated Protein C Suppresses Cardiomyocyte Senescence in Diabetic Cardiomyopathy via PAR1/PAR3-P85-CaMKIIdelta Axis.
    Diabetes. 2025 Aug 15:db250077. doi: 10.2337/db25-0077.
    PubMed     Abstract available
    
    
    
25. HOSOE S, Katakami N, Taya N, Omori K, et al
    Association Between Myristic Acid in Plasma Triglycerides and Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: A Comprehensive Analysis of Plasma Lipids Using Supercritical Fluid Chromatography-Tandem Mass Spe
    Diabetes. 2025 Aug 14:db250099. doi: 10.2337/db25-0099.
    PubMed     Abstract available
    
    
    
26. DENG B, Nnebe C, Prakhar P, Ren X, et al
    New Insights Into Diabetes-Induced Cell-Type-Specific Responses in the Neural Retina via Single-Cell Transcriptomics: A Report on Research Supported by Pathway to Stop Diabetes.
    Diabetes. 2025 Aug 12:dbi240009. doi: 10.2337/dbi24-0009.
    PubMed     Abstract available
    
    
    
27. CARTWRIGHT BR, Scherer PE
    Adipose Tissue as a Target for Precision Medicine Approaches in Childhood Obesity.
    Diabetes. 2025 Aug 12:dbi240044. doi: 10.2337/dbi24-0044.
    PubMed     Abstract available
    
    
    
28. ZHOU X, Iakovliev A, McGurnaghan S, Erabadda B, et al
    Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes.
    Diabetes. 2025 Aug 11:db250067. doi: 10.2337/db25-0067.
    PubMed     Abstract available
    
    
    
29. TORCHIO S, Siracusano G, Cuozzo F, Zamarian V, et al
    Erratum. Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell-Derived beta-Cells Harboring a Partially Functional WFS1 Variant. Diabetes 2025;74:1273-1288.
    Diabetes. 2025 Aug 5:db25er10a. doi: 10.2337.
    PubMed     Abstract available
    
    
    
30. PAGE B
    Diabetes Spotlight: Darleen Sandoval, PhD-Understanding Metabolism Through the Gut-Brain Axis.
    Diabetes. 2025;74:1311-1312.
    PubMed    
    
    
    
31. DE VITO F, Marasco R, Suraci E, Facciolo A, et al
    FXR Stimulation by Obeticholic Acid Treatment Restores Gut Mucosa Functional and Structural Integrity in Individuals With Altered Glucose Tolerance.
    Diabetes. 2025;74:1399-1410.
    PubMed     Abstract available
    
    
    July 2025
32. EVANS-MOLINA C, Dor Y, Lernmark A, Mathieu C, et al
    The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetes. 2025 Jul 30:dbi250011. doi: 10.2337/dbi25-0011.
    PubMed     Abstract available
    
    
    
33. DROTAR DM, Vazquez Ramos GJA, Williams MD, David ST, et al
    Loss of Insulin-Positive Cell Clusters Precedes the Decrease in Islet Frequency and beta-Cell Area in Type 1 Diabetes.
    Diabetes. 2025 Jul 24:db250326. doi: 10.2337/db25-0326.
    PubMed     Abstract available
    
    
    
34. LI S, Zhou J, Wallace ED, Ehrmann BM, et al
    Impacts of Metabolic Reprogramming on the Onset of Diabetic Nephropathy in Mice With Varying Lias Gene Expression Levels.
    Diabetes. 2025 Jul 15:db241013. doi: 10.2337/db24-1013.
    PubMed     Abstract available
    
    
    
35. MARINAC M, Rickels MR, Gaglia JL, O'Connell PJ, et al
    Future Directions and Clinical Trial Considerations for Novel Islet beta-Cell Replacement Therapies for Type 1 Diabetes.
    Diabetes. 2025 Jul 15:dbi240037. doi: 10.2337/dbi24-0037.
    PubMed     Abstract available
    
    
    
36. NECTOW AR
    The Dorsal Raphe Nucleus and the Integrative Control of Feeding: A Report on Research Supported by Pathway to Stop Diabetes.
    Diabetes. 2025 Jul 15:dbi240015. doi: 10.2337/dbi24-0015.
    PubMed     Abstract available
    
    
    
37. WASSERFALL CH, Forsmark CE, Li S, Li L, et al
    Type 1 Diabetes Autoantibodies in Acute, Recurrent Acute, and Chronic Pancreatitis.
    Diabetes. 2025 Jul 9:db240931. doi: 10.2337/db24-0931.
    PubMed     Abstract available
    
    
    
38. REN X, Zhang G, Zhou B, Gu W, et al
    Revealing Cerebral Microvascular Changes in Diabetic Rodents With Ultrasound Localization Microscopy.
    Diabetes. 2025 Jul 8:db250007. doi: 10.2337/db25-0007.
    PubMed     Abstract available
    
    
    
39. SVANE MS, Hindso M, Martinussen C, Dirksen C, et al
    beta-Cell Function and Sensitivity to Incretins Before and After Roux-en-Y Gastric Bypass in Individuals With Type 2 Diabetes.
    Diabetes. 2025 Jul 3:db241054. doi: 10.2337/db24-1054.
    PubMed     Abstract available
    
    
    
40. PAGE B
    Diabetes Spotlight: Carmella Evans-Molina, MD, PhD-Charting beta-Cell Dysfunction to Delay the Onset of Type 1 Diabetes.
    Diabetes. 2025;74:1035-1036.
    PubMed    
    
    
    
41. MA Y, Zuo S, Lo T, Phan D, et al
    Genetic Variations in GCKR and PNPLA3 Regulate Metabolic Balance Across the Liver.
    Diabetes. 2025;74:1300-1309.
    PubMed     Abstract available
    
    
    
42. TORCHIO S, Siracusano G, Cuozzo F, Zamarian V, et al
    Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell-Derived beta-Cells Harboring a Partially Functional WFS1 Variant.
    Diabetes. 2025;74:1273-1288.
    PubMed     Abstract available
    
    
    
43. YANG D, Qiao B, Bai F, Duan J, et al
    Surface Modification of Islets With L-DOPA-KF7 Enhances Islet Survival by Inhibiting IBMIR in Intrahepatic Islet Transplantation.
    Diabetes. 2025;74:1184-1195.
    PubMed     Abstract available
    
    
    June 2025
44. SHEANON N, Warner SO, Dai Y, Whitsett NH, et al
    Fasting Lowers Glucagon Levels Under Basal Conditions and During Insulin-Induced Hypoglycemia in Individuals With Type 1 Diabetes.
    Diabetes. 2025 Jun 30:db250251. doi: 10.2337/db25-0251.
    PubMed     Abstract available
    
    
    
45. GIANFRANI C, Camarca A, Picascia S, Vitale S, et al
    T-Cell Mediated Immunity to Gliadin Is Elicited in the Gut Mucosa of Type 1 Diabetes Patients Only in Presence of Celiac Disease Comorbidity.
    Diabetes. 2025 Jun 24:db241120. doi: 10.2337/db24-1120.
    PubMed     Abstract available
    
    
    
46. BERG-HANSEN K, Bangshaab M, Gopalasingam N, Nielsen R, et al
    The Cardiac and Hemodynamic Effects of Ketone Bodies Are Abnormal in Patients With Type 1 Diabetes: A Randomized Controlled Trial.
    Diabetes. 2025 Jun 17:db250243. doi: 10.2337/db25-0243.
    PubMed     Abstract available
    
    
    
47. ONTKO CD, Smith TE, Stark AK, Olson JC, et al
    Cannabinoid Receptor 2 Agonism Demonstrates Therapeutic Potential in Experimental Models of Relevance to Diabetic Retinopathy.
    Diabetes. 2025 Jun 12:db240805. doi: 10.2337/db24-0805.
    PubMed     Abstract available
    
    
    
48. PIPELLA J, Motlagh RA, Rampazzo Morelli N, Thompson PJ, et al
    Autoreactive T Cells and Cytokine Stress Drive beta-Cell Senescence Entry and Accumulation in Type 1 Diabetes.
    Diabetes. 2025 Jun 11:db241122. doi: 10.2337/db24-1122.
    PubMed     Abstract available
    
    
    
49. MAURAS N, Ma Q, Weinzimer SA, White NH, et al
    Differences in White Matter Microstructure in Children With Type 1 Diabetes Persist During Longitudinal Follow-up: Relation to Dysglycemia.
    Diabetes. 2025 Jun 2:db240684. doi: 10.2337/db24-0684.
    PubMed     Abstract available
    
    
    
50. CEROSALETTI K, Kent SC
    Expanding the Case for Hybrid Insulin Peptides in Type 1 Diabetes.
    Diabetes. 2025;74:870-872.
    PubMed    
    
    
    
51. PAGE B
    Diabetes Spotlight: Soo Heon Kwak, MD, PhD-Advancing Precision Medicine in Diabetes Through Genetic Insights.
    Diabetes. 2025;74:861-862.
    PubMed    
    
    
    
52. AKHBARI P, Perez-Hernandez J, Russell MA, Dhayal S, et al
    Soluble HLA Class I Is Released From Human beta-Cells Following Exposure to Interferons.
    Diabetes. 2025;74:956-968.
    PubMed     Abstract available
    
    
    
53. WATSON TK, Rosen ABI, Drow T, Medjo JA, et al
    Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell-Intrinsic Immune Tolerance.
    Diabetes. 2025;74:943-955.
    PubMed     Abstract available
    
    
    
54. THOMSON EA, Lee S, Xu H, Moeller H, et al
    Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics.
    Diabetes. 2025;74:873-884.
    PubMed     Abstract available
    
    
    
55. BRUCE CR, Ang T, Toms JD, Dao GM, et al
    The Effect of Small Increases in Blood Glucose on Insulin Secretion and Endogenous Glucose Production in Humans.
    Diabetes. 2025;74:898-906.
    PubMed     Abstract available
    
    
    May 2025
56. RUCHI FNU, Schiavon M, Yadav Y, Dalla Man C, et al
    Splanchnic and Leg Glucagon Metabolism in Healthy and Type 1 Diabetes: First in Human Study Using [13C9, 15N1]-Glucagon.
    Diabetes. 2025 May 30:db241064. doi: 10.2337/db24-1064.
    PubMed     Abstract available
    
    
    
57. WANG W, Yu X, Yang Z, Zhang Y, et al
    Codelivery of NGFR100W and VEGFA mRNA Enhances Vascular and Neural Repair in Diabetic Peripheral Neuropathy.
    Diabetes. 2025 May 28:db240989. doi: 10.2337/db24-0989.
    PubMed     Abstract available
    
    
    
58. FAN KS, Shojaee-Moradie F, Jeivad F, Manoli A, et al
    A Dual Stable Isotope Study of the Effect of Altitude and Simulated Flight on Glucose Metabolism in Type 1 Diabetes: A Randomized Crossover Study.
    Diabetes. 2025 May 28:db250004. doi: 10.2337/db25-0004.
    PubMed     Abstract available
    
    
    
59. WILLIAMS JM, Hilmes MA, Letourneau-Freiberg LR, Kandasamy B, et al
    Smaller Pancreas Volume in Insulin-Dependent Monogenic Diabetes.
    Diabetes. 2025 May 22:db250318. doi: 10.2337/db25-0318.
    PubMed     Abstract available
    
    
    
60. CHAN JSF, Ussher JR
    Of Mice and Men: Toward a Better Model of Diabetic Cardiomyopathy With Application in Female Animals.
    Diabetes. 2025;74:689-690.
    PubMed    
    
    
    
61. D'ALESSIO D, Kahn SE
    The Normal 93: Linking the beta-Cell and Insulin Sensitivity: Revisiting a 1993 Diabetes Classic by Kahn et al.
    Diabetes. 2025;74:668-671.
    PubMed     Abstract available
    
    
    
62. PAGE B
    Diabetes Spotlight: Kirk Habegger, PhD: The Impact of Glucagon on Metabolic Processes.
    Diabetes. 2025;74:665.
    PubMed    
    
    
    
63. YOUSUF MS, Mancilla Moreno M, Woodall BJ, Thakur V, et al
    Diroximel Fumarate Acts Through Nrf2 to Attenuate Methylglyoxal-Induced Nociception in Mice and Decrease ISR Activation in DRG Neurons.
    Diabetes. 2025;74:827-837.
    PubMed     Abstract available
    
    
    
64. YANG S, Xiong L, Liao T, Li L, et al
    Deubiquitinating Enzyme USP2 Alleviates Muscle Atrophy by Stabilizing PPAR-gamma.
    Diabetes. 2025;74:773-786.
    PubMed     Abstract available
    
    
    
65. FLATT AJ, Matus AM, Gallop RJ, Markmann E, et al
    beta-Cell Secretory Capacity Predicts Metabolic Outcomes Over 6 Years After Human Islet Transplantation.
    Diabetes. 2025;74:749-759.
    PubMed     Abstract available
    
    
    April 2025
66. ROMAN J, Yuan Y, Xu Y, Zhu Q, et al
    A functional and mechanistic explanation for the unique clinical success of the glucokinase activator dorzagliatin for treatment of type 2 diabetes.
    Diabetes. 2025 Apr 24:db250066. doi: 10.2337/db25-0066.
    PubMed     Abstract available
    
    
    
67. SCALA R, Li Y, Gao J, York NW, et al
    Paradoxical maturity-onset diabetes of the young (MODY) arising from loss-of-function mutations in ATP-sensitive potassium channels.
    Diabetes. 2025 Apr 24:db250110. doi: 10.2337/db25-0110.
    PubMed     Abstract available
    
    
    
68. LI D, Zhang J, Han X, Kong L, et al
    Targeting tsRNA-1797 alleviates diabetes-induced vascular dysfunction through modulating purine metabolism.
    Diabetes. 2025 Apr 24:db241158. doi: 10.2337/db24-1158.
    PubMed     Abstract available
    
    
    
69. CEFALU WT, Cerio RJ, Silva CM, Wallace JA, et al
    NIDDK: Celebrating 75 Years of Advancing Diabetes Research.
    Diabetes. 2025 Apr 24:dbi250023. doi: 10.2337/dbi25-0023.
    PubMed    
    
    
    
70. HERING BJ, Rickels MR, Bellin MD, Millman JR, et al
    Advances in Cell Replacement Therapies for Diabetes.
    Diabetes. 2025 Apr 24:db250037. doi: 10.2337/db25-0037.
    PubMed     Abstract available
    
    
    
71. PARENT AV, Agarwal A, Alvarez-Dominguez JR, Arrojo E Drigo R, et al
    Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative.
    Diabetes. 2025 Apr 24:db250097. doi: 10.2337/db25-0097.
    PubMed     Abstract available
    
    
    
72. JONES TLZ, Kusmartseva I, Litovsky S, Thakar R, et al
    The Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D): An NIDDK Initiative to Advance Understanding of Mechanisms Underlying Cardiovascular Disease in Type 1 Versus Type 2 Diabetes.
    Diabetes. 2025 Apr 24:db250017. doi: 10.2337/db25-0017.
    PubMed     Abstract available
    
    
    
73. COSTANZO MC, Akolkar B, Claussnitzer M, Florez JC, et al
    Accelerating Medicines Partnership in Type 2 Diabetes and Common Metabolic Diseases: Collaborating to Maximize the Value of Genetic and Genomic Data.
    Diabetes. 2025 Apr 24:db250042. doi: 10.2337/db25-0042.
    PubMed     Abstract available
    
    
    
74. SILVA CM, Thornton PL, Artis Dickerson S, Eggerman TL, et al
    Celebrating the Past, Present, and Future of NIDDK-Supported Research Centers Focused on Diabetes, Endocrinology, and Metabolic Diseases.
    Diabetes. 2025 Apr 24:db250039. doi: 10.2337/db25-0039.
    PubMed     Abstract available
    
    
    
75. LI H, Xu L, Venkata SPM, Minjares M, et al
    G protein-coupled receptor 35 suppresses oxidative stress response 1 in diabetic wound healing.
    Diabetes. 2025 Apr 23:db240737. doi: 10.2337/db24-0737.
    PubMed     Abstract available
    
    
    
76. DUH EJ, Xu Z, Cho H, Wu S, et al
    Neuroprotective Effect of a Novel Soluble Guanylate Cyclase Activator (sGCa) Runcaciguat in Diabetes and Ischemic Retinopathy.
    Diabetes. 2025 Apr 18:db240739. doi: 10.2337/db24-0739.
    PubMed     Abstract available
    
    
    
77. BUCHANAN TA, Xiang AH, Page KA, Watanabe RM, et al
    What is Gestational Diabetes - Really?
    Diabetes. 2025 Apr 8:dbi240041. doi: 10.2337/dbi24-0041.
    PubMed     Abstract available
    
    
    
78. HAGIWARA S, Okabe J, Ziemann M, Drew B, et al
    miR-214 and its primary transcript Dnm3os regulate fibrosis and inflammation through RAGE signalling in diabetic kidney disease.
    Diabetes. 2025 Apr 4:db240121. doi: 10.2337/db24-0121.
    PubMed     Abstract available
    
    
    
79. ISMAIL HM, Cuthbertson D, Galderisi A, Libman I, et al
    The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes.
    Diabetes. 2025 Apr 2:db241000. doi: 10.2337/db24-1000.
    PubMed     Abstract available
    
    
    
80. BILAL A, Casu A, Yi F, Dutta T, et al
    A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
    Diabetes. 2025 Apr 2:db250096. doi: 10.2337/db25-0096.
    PubMed     Abstract available
    
    
    
81. PAGE B
    Diabetes Spotlight: Alice Y.Y. Cheng, MD, FRCPC: Distilling the Complex Language of Clinical Research.
    Diabetes. 2025;74:453.
    PubMed    
    
    
    
82. BASU L, Grieco-St-Pierre L, Ching MEA, Stead JDH, et al
    Cisplatin Exposure Dysregulates Insulin Secretion in Male and Female Mice.
    Diabetes. 2025;74:528-543.
    PubMed     Abstract available
    
    
    
83. 
    A Special Thanks to the Reviewers of Diabetes.
    Diabetes. 2025;74:454.
    PubMed     Abstract available
    
    
    March 2025
84. JIANG A, Wei H, Chu S, Wang M, et al
    Up-regulation of acid-sensing ion channel 1a in the anterior cingulate cortex by TNF-alpha/NF-kappaB pathway contributes to diabetes-related pain.
    Diabetes. 2025 Mar 25:db240847. doi: 10.2337/db24-0847.
    PubMed     Abstract available
    
    
    
85. ALCOVER S, Lopez S, Ramos L, Munoz-Garcia N, et al
    Cardioprotection during myocardial infarction in diabetic cardiomyopathy.
    Diabetes. 2025 Mar 13:db240510. doi: 10.2337/db24-0510.
    PubMed     Abstract available
    
    
    
86. KRISCHER JP, Muller S, You L, Achenbach P, et al
    A Comparative Analysis of the Sensitivity, Specificity, Concordance, and the 5-year Predictive Power of Diabetes-related Autoantibody Assays.
    Diabetes. 2025 Mar 10:db240814. doi: 10.2337/db24-0814.
    PubMed     Abstract available
    
    
    
87. GURUNG RL, Liu JJ, Liu S, Lee J, et al
    Association of plasma angiogenin with risk of incident end-stage kidney disease in individuals with type 2 diabetes.
    Diabetes. 2025 Mar 4:db240699. doi: 10.2337/db24-0699.
    PubMed     Abstract available
    
    
    
88. BOHOVYK R, Staruschenko A
    Targeting REDD1 in Podocytes: A Promising Strategy for Mitigating Diabetic Kidney Injury.
    Diabetes. 2025;74:265-267.
    PubMed    
    
    
    
89. PAGE B
    Diabetes Spotlight: Lisa Chow, MD, MS: Quantifiable Lifestyle Changes to Improve Diabetes Outcomes.
    Diabetes. 2025;74:251.
    PubMed    
    
    
    
90. FINSTERER J
    Comment on Chanoine et al. Is Hyperactive mTORC1 Signaling Responsible for the Phenotypic Expression (Diabetes, Hypoacusis) of the m.3243A>G Variant?
    Diabetes. 2025;74:e6-e7.
    PubMed    
    
    
    
91. MANDUCHI E, Descamps HC, Schug J, Da T, et al
    Response to Comment on Manduchi et al. No Evidence for Persistent Enteroviral B Infection of Pancreatic Islets in Patients With Type 1 Diabetes and Prediabetes From RNA Sequencing Data. Diabetes 2024;73:1697-1704.
    Diabetes. 2025;74:e5.
    PubMed    
    
    
    
92. CHANOINE JP, Thompson DM, Lehman A
    Response to Comment on Chanoine et al. Understanding the Complexity of MIDD Diabetes Mechanism With Dual Focus on beta-Cell Function and Insulin Sensitivity.
    Diabetes. 2025;74:e8-e9.
    PubMed    
    
    
    
93. VECCHIO F, Laiho JE, Hyoty H, Pugliese A, et al
    Comment on Manduchi et al. No Evidence for Persistent Enteroviral B Infection of Pancreatic Islets in Patients With Type 1 Diabetes and Prediabetes From RNA Sequencing Data. Diabetes 2024;73:1697-1704.
    Diabetes. 2025;74:e3-e4.
    PubMed    
    
    
    
94. D'ALESSIO DA
    Development of the Insulin Radioimmunoassay, the Watershed Moment in Diabetes Research: Revisiting 1960 Diabetes Classics by Berson and Yalow.
    Diabetes. 2025;74:252-254.
    PubMed     Abstract available
    
    
    February 2025
95. LEE J, Ustione A, Wilkerson EM, Balakrishnan R, et al
    Regulation of Type 1 Diabetes via Brown Adipocyte-Secreted Proteins and the Novel Glucagon Regulator Nidogen-2.
    Diabetes. 2025 Feb 28:db241003. doi: 10.2337/db24-1003.
    PubMed     Abstract available
    
    
    
96. WEI Y, Huang Y, Huang R, Ruan Y, et al
    Antihypertensive drug amlodipine besylate shows potential in alleviating diabetic peripheral neuropathy.
    Diabetes. 2025 Feb 28:db240403. doi: 10.2337/db24-0403.
    PubMed     Abstract available
    
    
    
97. MOHAMMED SA, Gorica E, Albiero M, Karsai G, et al
    Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G.
    Diabetes. 2025 Feb 27:db240997. doi: 10.2337/db24-0997.
    PubMed     Abstract available
    
    
    
98. CHAN CK, Yang WS, Lin YH, Wu VC, et al
    Unilateral Primary Aldosteronism Lacking KCNJ5 Somatic Mutations is Associated with an Elevated Risk of New-Onset Diabetes Mellitus.
    Diabetes. 2025 Feb 25:db230273. doi: 10.2337/db23-0273.
    PubMed     Abstract available
    
    
    
99. XIE QY, Granato A, Wong A, Yau C, et al
    Metabolic dysfunction associated with alterations in gut microbiota in adolescents with obesity.
    Diabetes. 2025 Feb 21:db240866. doi: 10.2337/db24-0866.
    PubMed     Abstract available
    
    
    
100. VOS S, Portillo JC, Hubal A, Bapputty R, et al
     CD40 INDUCES UNFOLDED PROTEIN RESPONSE, UPREGULATION OF VEGF AND VASCULAR LEAKAGE IN DIABETIC RETINOPATHY.
     Diabetes. 2025 Feb 20:db230538. doi: 10.2337/db23-0538.
     PubMed     Abstract available
     
     
     
101. LI Q, Onizuka S, Park K, Ma M, et al
     Differential Effects of Retinol-Binding Protein 3 and Anti-VEGF Antibodies on Retinal Dysfunctions in Diabetic Retinopathy.
     Diabetes. 2025 Feb 12:db240822. doi: 10.2337/db24-0822.
     PubMed     Abstract available
     
     
     
102. WANG Y, Xia C, Li M, Xu G, et al
     Comparison of the Effects of SGLT-2i versus GLP-1RA on Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus based on Baseline Renal Function.
     Diabetes. 2025 Feb 11:db240688. doi: 10.2337/db24-0688.
     PubMed     Abstract available
     
     
     
103. D'ALESSIO DA
     Diabetes Spotlight: A New Addition to the Journal.
     Diabetes. 2025;74:133.
     PubMed    
     
     
     
104. HOLMAN RR
     The Science of Diabetes and a Life of Trials: The 2024 Banting Medal for Scientific Achievement Award Lecture.
     Diabetes. 2025;74:164-174.
     PubMed    
     
     
     
105. HOROWITZ JF, Goodpaster BH
     Mechanistic Insights Into the Exercise-Induced Changes in Muscle Lipids and Insulin Sensitivity-Expanding on the "Athlete's Paradox": Revisiting a 2011 Diabetes Classic by Amati et al.
     Diabetes. 2025;74:134-137.
     PubMed     Abstract available
     
     
     January 2025
106. ZHANG J, Jiao F, Wang Z, Zou C, et al
     Identification of CD209 as an Intervention Target for Type 2 Diabetes after COVID-19 Infection: Insights from Proteome-wide Mendelian Randomization.
     Diabetes. 2025 Jan 28:db240677. doi: 10.2337/db24-0677.
     PubMed     Abstract available
     
     
     
107. ZENG T, Sun K, Mai L, Hong X, et al
     Extracellular vesicle-associated miR-ERIA exerts the anti-angiogenic effect of macrophages in diabetic wound healing.
     Diabetes. 2025 Jan 24:db240701. doi: 10.2337/db24-0701.
     PubMed     Abstract available
     
     
     
108. KARATZIA L, Cullen F, Young M, Lam SH, et al
     A new model of experimental diabetic cardiomyopathy using combination of multiple doses of anomer-equilibrated streptozotocin and high fat diet: sex matters.
     Diabetes. 2025 Jan 21:db240385. doi: 10.2337/db24-0385.
     PubMed     Abstract available
     
     
     
109. JIA X, Wenzlau JM, Zhang C, Dong F, et al
     Strong Association of Autoantibodies Targeting Deamidated Extracellular Epitopes of Insulinoma Antigen-2 (IA-2) with Clinical Onset of Type 1 Diabetes.
     Diabetes. 2025 Jan 16:db240571. doi: 10.2337/db24-0571.
     PubMed     Abstract available
     
     
     
110. HOHENSTEIN AC, Gallegos J, Dang M, Groegler J, et al
     Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects.
     Diabetes. 2025 Jan 16:db240611. doi: 10.2337/db24-0611.
     PubMed     Abstract available
     
     
     
111. WEI J, Yu Y, Wu H, Li Y, et al
     Clonal haematopoiesis of indeterminate potential and risk of microvascular complications among individuals with type 2 diabetes: a cohort study.
     Diabetes. 2025 Jan 13:db240841. doi: 10.2337/db24-0841.
     PubMed     Abstract available
     
     
     
112. LIN J, Zhang X, Ge W, Duan Y, et al
     Rnd3 Ameliorates Diabetic Cardiac Microvascular Injury via Facilitating Trim40-mediated Rock1 Ubiquitination.
     Diabetes. 2025 Jan 10:db240543. doi: 10.2337/db24-0543.
     PubMed     Abstract available
     
     
     
113. KWIATKOWSKA KM, Garagnani P, Bonafe M, Bacalini MG, et al
     High-resolution whole-genome DNA methylation revealed unique signatures of painful diabetic neuropathy.
     Diabetes. 2025 Jan 8:db240930. doi: 10.2337/db24-0930.
     PubMed     Abstract available
     
     
     
114. QUAST DR, Xie C, Bound MJ, Grivell J, et al
     Effects of metformin on postprandial blood pressure, heart rate, gastric emptying, GLP-1 and the prevalence of postprandial hypotension in type 2 diabetes - a double-blind, placebo-controlled crossover study.
     Diabetes. 2025 Jan 6:db240830. doi: 10.2337/db24-0830.
     PubMed     Abstract available
     
     
     
115. LU T, Manousaki D, Sun L, Paterson AD, et al
     Integrative proteogenomic analyses provide novel interpretations of type 1 diabetes risk loci through circulating proteins.
     Diabetes. 2025 Jan 6:db240380. doi: 10.2337/db24-0380.
     PubMed     Abstract available
     
     
     
116. YANG WX, Su K, Liao MC, Zhou J, et al
     Renal Tubule-Specific Angiotensinogen Deletion Attenuates SGLT2 Expression and Ameliorates Diabetic Kidney Disease in Murine Models of Type 1 Diabetes.
     Diabetes. 2025 Jan 3:db240553. doi: 10.2337/db24-0553.
     PubMed     Abstract available
     
     
     
117. D'ALESSIO DA, Kahn SE
     The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.
     Diabetes. 2025;74:1-3.
     PubMed    
     
     
     
118. LU J, Ni J, Su H, He X, et al
     One-Hour Postload Glucose Is a More Sensitive Marker of Impaired beta-Cell Function Than Two-Hour Postload Glucose.
     Diabetes. 2025;74:36-42.
     PubMed     Abstract available
     
     
     
119. RUSSO GT, Nicolucci A, Lucisano G, Rossi MC, et al
     When Does Metabolic Memory Start? Insights From the Association of Medical Diabetologists Annals Initiative on Stringent HbA1c Targets.
     Diabetes. 2025;74:75-81.
     PubMed     Abstract available
     
     
     
120. XING X, Xu S, Wang Y, Shen Z, et al
     Evaluating the Causal Effect of Circulating Proteome on Glycemic Traits: Evidence From Mendelian Randomization.
     Diabetes. 2025;74:108-119.
     PubMed     Abstract available
     
     
     December 2024
121. MARCHIORI M, Maguolo A, Perfilyev A, Maziarz M, et al
     Blood-based epigenetic biomarkers associated with incident chronic kidney disease in individuals with type 2 diabetes.
     Diabetes. 2024 Dec 23:db240483. doi: 10.2337/db24-0483.
     PubMed     Abstract available
     
     
     
122. NISHIKAWA K, Murakami T, Yoshida M, Terada N, et al
     Extracellular Mitochondria Exacerbate Retinal Pigment Epithelium Degeneration in Diabetic Retinopathy.
     Diabetes. 2024 Dec 23:db240040. doi: 10.2337/db24-0040.
     PubMed     Abstract available
     
     
     
123. LI A, Gong S, Yu C, Pei P, et al
     Phenotypic vs. Genetic Mismatch of BMI and Type 2 Diabetes: Evidence from Two Perspective Cohort Studies.
     Diabetes. 2024 Dec 10:db240736. doi: 10.2337/db24-0736.
     PubMed     Abstract available
     
     
     
124. LIM CGY, Ozkan B, Liang Y, Chen J, et al
     Plasma proteomic signatures of adiposity are associated with cardiovascular risk factors and type 2 diabetes risk in a multi-ethnic Asian population.
     Diabetes. 2024 Dec 2:db240184. doi: 10.2337/db24-0184.
     PubMed     Abstract available
     
     
     
125. DEBARBA LK, Jayarathne HSM, Stilgenbauer L, Dos Santos ALT, et al
     Microglia Mediate Metabolic Dysfunction From Common Air Pollutants Through NF-kappaB Signaling.
     Diabetes. 2024;73:2065-2077.
     PubMed     Abstract available
     
     
     November 2024
126. NG STH, Price MJ, Richardson N, Nawaf M, et al
     Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes.
     Diabetes. 2024 Nov 21:db230996. doi: 10.2337/db23-0996.
     PubMed     Abstract available
     
     
     
127. TOKGOZ S, Boss M, Jansen TJ, Meijer R, et al
     Activation of the HPA axis does not explain non-responsiveness to GLP-1R agonist treatment in individuals with type 2 diabetes.
     Diabetes. 2024 Nov 19:db240463. doi: 10.2337/db24-0463.
     PubMed     Abstract available
     
     
     
128. WANG X, Ma H, Kou M, Heianza Y, et al
     Proteomic Signature of Body Mass Index and Risk of Type 2 Diabetes.
     Diabetes. 2024 Nov 19:db240329. doi: 10.2337/db24-0329.
     PubMed     Abstract available
     
     
     
129. ROSHANDEL D, Spiliopoulou A, McGurnaghan SJ, Iakovliev A, et al
     Genetics of C-peptide and Age at Diagnosis in Type 1 Diabetes.
     Diabetes. 2024 Nov 18:db240340. doi: 10.2337/db24-0340.
     PubMed     Abstract available
     
     
     
130. MCNITT DH, Williams JM, Santitoro JG, Kim J, et al
     Type 1 diabetes depends on CD4-driven expression of the transcriptional repressor, Bcl6.
     Diabetes. 2024 Nov 18:db230709. doi: 10.2337/db23-0709.
     PubMed     Abstract available
     
     
     
131. CHANOINE JP, Thompson DM, Lehman A
     Diabetes Mellitus Associated with Maternally Inherited Diabetes and Deafness (MIDD): From Pathogenic Variant to Phenotype.
     Diabetes. 2024 Nov 18:db240515. doi: 10.2337/db24-0515.
     PubMed     Abstract available
     
     
     
132. HARNOIS-LEBLANC S, Hivert MF
     Stopping the intergenerational risk of diabetes - from mechanisms to interventions.
     Diabetes. 2024 Nov 18:dbi240014. doi: 10.2337/dbi24-0014.
     PubMed     Abstract available
     
     
     
133. KANG M, Son K, Hwang YC, Lee S, et al
     Identification of Metabolic Patterns in Korean Patients with Type 2 Diabetes Mellitus and their Association with Diabetes-Related Complications.
     Diabetes. 2024 Nov 15:db230798. doi: 10.2337/db23-0798.
     PubMed     Abstract available
     
     
     
134. KONG X, Yan D, Shao L, Li B, et al
     Increased COX6A2 promotes pancreatic beta-cell apoptosis and is suppressed in diabetic GK rats after Roux-en-Y gastric bypass.
     Diabetes. 2024 Nov 15:db240301. doi: 10.2337/db24-0301.
     PubMed     Abstract available
     
     
     
135. YUAN S, Yu Q, Luo M, Wu J, et al
     Friend or foe: the paradoxical roles of MG53 in diabetes mellitus.
     Diabetes. 2024 Nov 13:db240556. doi: 10.2337/db24-0556.
     PubMed     Abstract available
     
     
     
136. LUCKETT AM, Hawkes G, Green HD, De Franco E, et al
     Type 1 diabetes genetic risk contributes to phenotypic presentation in monogenic autoimmune diabetes.
     Diabetes. 2024 Nov 12:db240485. doi: 10.2337/db24-0485.
     PubMed     Abstract available
     
     
     
137. CARTER EB
     Innovating Diabetes Care in Pregnancy: Do group care models improve outcomes and equity?
     Diabetes. 2024 Nov 12:dbi240006. doi: 10.2337/dbi24-0006.
     PubMed     Abstract available
     
     
     
138. RAJESH LENIN R, Monickaraj F
     Comment on Yang et al. Deciphering the Connection Between Microvascular Damage and Neurodegeneration in Early Diabetic Retinopathy. Diabetes 2024;73:1883-1894.
     Diabetes. 2024 Nov 11:db240629. doi: 10.2337/db24-0629.
     PubMed    
     
     
     
139. GARDNER TW, Bek T
     Dissecting the Neurovascular Unit in Human Diabetic Retinal Disease.
     Diabetes. 2024;73:1791-1792.
     PubMed    
     
     
     
140. DAVIDSON MB
     Comment on Mittendorfer et al. Insulin Hypersecretion as Promoter of Body Fat Gain and Hyperglycemia. Diabetes 2024;73:837-843.
     Diabetes. 2024;73:e11.
     PubMed    
     
     
     
141. MITTENDORFER B, Johnson JD, Solinas G, Jansson PA, et al
     Response to Comment on Mittendorfer et al. Insulin Hypersecretion as Promoter of Body Fat Gain and Hyperglycemia. Diabetes 2024;73:837-843.
     Diabetes. 2024;73:e12.
     PubMed    
     
     
     October 2024
142. CONG L, Qi B, Chen S, Liu R, et al
     Long-term nerve regeneration in diabetic keratopathy mediated by a novel NGF delivery system.
     Diabetes. 2024 Oct 24:db240393. doi: 10.2337/db24-0393.
     PubMed     Abstract available
     
     
     
143. MALLONE R, Sims E, Achenbach P, Mathieu C, et al
     Emerging concepts and success stories in type 1 diabetes research: a roadmap for a bright future.
     Diabetes. 2024 Oct 24:db240439. doi: 10.2337/db24-0439.
     PubMed     Abstract available
     
     
     
144. LIN CH, Wu MR, Tanasa B, Prakhar P, et al
     Induction of a Muller glial-specific protective pathway safeguards the retina from diabetes induced damage.
     Diabetes. 2024 Oct 24:db240199. doi: 10.2337/db24-0199.
     PubMed     Abstract available
     
     
     
145. FENG S, Zhang Q, Liu Q, Huang C, et al
     N 6-Methyladenosine demethylase FTO controls macrophage homeostasis in diabetic vasculopathy.
     Diabetes. 2024 Oct 24:db240691. doi: 10.2337/db24-0691.
     PubMed     Abstract available
     
     
     
146. SOLIS-HERRERA C, Qin Y, Honka H, Cersosimo E, et al
     Effect of Hyperketonemia on Myocardial Function in Patients with Heart Failure and Type 2 Diabetes.
     Diabetes. 2024 Oct 24:db240406. doi: 10.2337/db24-0406.
     PubMed     Abstract available
     
     
     
147. MONTASER H, Leppanen S, Vahakangas E, Back N, et al
     IER3IP1 mutations cause neonatal diabetes due to impaired proinsulin trafficking.
     Diabetes. 2024 Oct 23:db240119. doi: 10.2337/db24-0119.
     PubMed     Abstract available
     
     
     
148. PAGE KA
     Neurodevelopmental Pathways to Obesity and Type 2 Diabetes: Insights From Prenatal Exposure to Maternal Obesity and Gestational Diabetes Mellitus: A Report on Research Supported by Pathway to Stop Diabetes.
     Diabetes. 2024 Oct 21:dbi240012. doi: 10.2337/dbi24-0012.
     PubMed     Abstract available
     
     
     
149. ROSOFF DB, Wagner J, Jung J, Pacher P, et al
     Multi-Omics Mendelian Randomization Study Investigating the Impact of PCSK9 and HMGCR Inhibition on Type 2 Diabetes Across Five Populations.
     Diabetes. 2024 Oct 17:db240451. doi: 10.2337/db24-0451.
     PubMed     Abstract available
     
     
     
150. FLAK JN
     Functionally Separate Populations of Ventromedial Hypothalamic Neurons in Obesity and Diabetes.
     Diabetes. 2024 Oct 17:dbi240011. doi: 10.2337/dbi24-0011.
     PubMed     Abstract available
     
     
     
151. SCHWARZ D, Marois ML, Sturm V, Peters AS, et al
     Exploring Structural and Molecular Features of Sciatic Nerve Lesions in Diabetic Neuropathy: Unveiling Pathogenic Pathways and Targets.
     Diabetes. 2024 Oct 17:db240493. doi: 10.2337/db24-0493.
     PubMed     Abstract available
     
     
     
152. TOWNSEND KL
     One Nervous System: Critical Links Between Central and Peripheral Nervous System Health and Implications for Obesity and Diabetes.
     Diabetes. 2024 Oct 14:dbi240004. doi: 10.2337/dbi24-0004.
     PubMed    
     
     
     
153. MIRZADEH Z, Faber C
     Brain Defense of Glycemia in Health and Diabetes.
     Diabetes. 2024 Oct 14:dbi240001. doi: 10.2337/dbi24-0001.
     PubMed    
     
     
     
154. LIU Z
     The Sensory Neuron-Mast Cell Axis Regulation of Skin Microcirculation in Diabetes: Implication for Diabetes-Related Cutaneous Complications.
     Diabetes. 2024;73:1563-1565.
     PubMed    
     
     
     
155. BARRA JM, Kratz AT, Castro-Gutierrez R, Proia J, et al
     Cryopreservation of Stem Cell-Derived beta-Like Cells Enriches for Insulin-Producing Cells With Improved Function.
     Diabetes. 2024;73:1687-1696.
     PubMed     Abstract available
     
     
     
156. TONG X, Yagan M, Hu R, Nevills S, et al
     Metabolic Stress Levels Influence the Ability of Myelin Transcription Factors to Regulate beta-Cell Identity and Survival.
     Diabetes. 2024;73:1662-1672.
     PubMed     Abstract available
     
     
     
157. GANGEMI CG, Janovjak H
     Optogenetics in Pancreatic Islets: Actuators and Effects.
     Diabetes. 2024;73:1566-1582.
     PubMed     Abstract available
     
     
     September 2024
158. SUNILKUMAR S, Yerlikaya EI, Toro AL, Chen H, et al
     Podocyte-Specific Expression of the Stress Response Protein REDD1 is Necessary for Diabetes-induced Podocytopenia.
     Diabetes. 2024 Sep 25:db240533. doi: 10.2337/db24-0533.
     PubMed     Abstract available
     
     
     
159. ALMUTAIRI A, White TD, Stephenson DJ, Stephenson BD, et al
     Selective Reduction of Ca2+-Independent Phospholipase A2beta (iPLA2beta)-Derived Lipid Signaling from Macrophages Mitigates Type 1 Diabetes Development.
     Diabetes. 2024 Sep 16:db230770. doi: 10.2337/db23-0770.
     PubMed     Abstract available
     
     
     
160. PETERSEN MC, Yoshino M, Smith GI, Gaspar RC, et al
     Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People with Obesity and Type 2 Diabetes.
     Diabetes. 2024 Sep 12:db240083. doi: 10.2337/db24-0083.
     PubMed     Abstract available
     
     
     
161. USSHER JR, Aasum E
     The Relationship Between Cardiac Energy Metabolism and Cardiac Function in Obesity and Type 2 Diabetes: Revisiting a 2003 Diabetes Classic by Aasum et al.
     Diabetes. 2024;73:1373-1376.
     PubMed    
     
     
     
162. RAY D, Loomis SJ, Venkataraghavan S, Zhang J, et al
     Characterizing Common and Rare Variations in Nontraditional Glycemic Biomarkers Using Multivariate Approaches on Multiancestry ARIC Study.
     Diabetes. 2024;73:1537-1550.
     PubMed     Abstract available
     
     
     
163. LIU Y, Wang S, Wang Z, Yu J, et al
     Recent Progress in Glucose-Responsive Insulin.
     Diabetes. 2024;73:1377-1388.
     PubMed     Abstract available
     
     
     August 2024
164. LIESE AD, Julceus EF, Rudisill C, Malik F, et al
     Erratum. 189-OR: Food Insecurity and Inability to Obtain Recommended Medications, Diabetes Technology, and Multidisciplinary Services in Youth and Young Adults with Diabetes. Diabetes 2024;73 (Suppl. 1):189-OR.
     Diabetes. 2024 Aug 29:db24er12b. doi: 10.2337.
     PubMed     Abstract available
     
     
     
165. HARAGUCHI T, Yamazaki Y, Kuwata H, Usui R, et al
     Glucagon Stimulation Test and Insulin Secretory Capacity in Clinical Assessment of Incretin-Based Therapy for Diabetes.
     Diabetes. 2024 Aug 28:db240518. doi: 10.2337/db24-0518.
     PubMed     Abstract available
     
     
     
166. FU S, Sun W, Liu L, Xiao J, et al
     Muller cells harboring exosomal lncRNA OGRU modulates microglia polarization in diabetic retinopathy via serving as miRNA sponges.
     Diabetes. 2024 Aug 23:db231015. doi: 10.2337/db23-1015.
     PubMed     Abstract available
     
     
     
167. GREENBAUM CJ, Nepom GT, Wood-Heickman LK, Wherrett DK, et al
     Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop.
     Diabetes. 2024 Aug 21:dbi240020. doi: 10.2337/dbi24-0020.
     PubMed     Abstract available
     
     
     
168. DHANAPALARATNAMA R, Issar T, Wang LL, Tran D, et al
     The effect of metformin on peripheral nerve morphology in type 2 diabetes: a cross-sectional observational study.
     Diabetes. 2024 Aug 21:db240365. doi: 10.2337/db24-0365.
     PubMed     Abstract available
     
     
     
169. SHEN Y, Shi R, Lu S, Wang Y, et al
     Role of Peptidyl arginine deiminase 4-dependent macrophage extracellular traps formation on Type 1 Diabetes pathogenesis.
     Diabetes. 2024 Aug 13:db231000. doi: 10.2337/db23-1000.
     PubMed     Abstract available
     
     
     
170. MAURIN L, Marselli L, Boissel M, Ning L, et al
     PNLIPRP1 hypermethylation in exocrine pancreas links type 2 diabetes and cholesterol metabolism.
     Diabetes. 2024 Aug 13:db240215. doi: 10.2337/db24-0215.
     PubMed     Abstract available
     
     
     
171. STANGL TA, Wiepjes CM, Smit RAJ, van Hylckama Vlieg A, et al
     The association between low sex hormone binding globulin and increased risk of type 2 diabetes is mediated by increased visceral and liver fat: results from observational and Mendelian randomization analyses.
     Diabetes. 2024 Aug 6:db230982. doi: 10.2337/db23-0982.
     PubMed     Abstract available
     
     
     
172. MARTINO M, Galderisi A, Evans-Molina C, Dayan C, et al
     Revisiting the pattern of loss of beta-cell function in preclinical Type 1 Diabetes.
     Diabetes. 2024 Aug 6:db240163. doi: 10.2337/db24-0163.
     PubMed     Abstract available
     
     
     
173. JAFFREDO M, Krentz NAJ, Champon B, Duff CE, et al
     Electrophysiological Characterization of Inducible Pluripotent Stem Cell-Derived Human beta-Like Cells and an SLC30A8 Disease Model.
     Diabetes. 2024;73:1255-1265.
     PubMed     Abstract available
     
     
     
174. BILLINGS LK, Jablonski KA, Pan Q, Florez JC, et al
     Increased Genetic Risk for beta-Cell Failure Is Associated With beta-Cell Function Decline in People With Prediabetes.
     Diabetes. 2024;73:1352-1360.
     PubMed     Abstract available
     
     
     July 2024
175. MANDUCHI E, Descamps HC, Schug J, Da T, et al
     No evidence for persistent enteroviral B infection of pancreatic islets in type 1 diabetic and pre-diabetic patients from RNA-Seq data.
     Diabetes. 2024 Jul 31:db240076. doi: 10.2337/db24-0076.
     PubMed     Abstract available
     
     
     
176. MANDUCHI E, Descamps HC, Schug J, Da T, et al
     No evidence for persistent enteroviral B infection of pancreatic islets in type 1 diabetic and pre-diabetic patients from RNA-Seq data.
     Diabetes. 2024 Jul 26:db240076. doi: 10.2337/db23-0076.
     PubMed     Abstract available
     
     
     
177. LI Y, Yang Y, Sun Y, He L, et al
     The miR-203/ZBTB20/MAFA axis orchestrates pancreatic beta-cell maturation and identity during weaning and diabetes.
     Diabetes. 2024 Jul 26:db230604. doi: 10.2337/db23-0604.
     PubMed     Abstract available
     
     
     
178. JEON HY, Lee AJ, Moon CH, Ha KS, et al
     Regulation of AMPK and GAPDH by transglutaminase 2 plays a pivotal role in microvascular leakage in diabetic retinas.
     Diabetes. 2024 Jul 18:db230885. doi: 10.2337/db23-0885.
     PubMed     Abstract available
     
     
     
179. GRACE SL, Gillespie KM, Williams CL, Lampasona V, et al
     Autoantibodies to truncated GAD(96-585) antigen stratify risk of early insulin requirement in adult-onset diabetes.
     Diabetes. 2024 Jul 8:db230980. doi: 10.2337/db23-0980.
     PubMed     Abstract available
     
     
     
180. DELLA PEPA G, Patricio BG, Carli F, Sabatini S, et al
     GLP-1 receptor agonist treatment improved fasting and postprandial lipidomic profile independently of diabetes and weight loss.
     Diabetes. 2024 Jul 8:db230972. doi: 10.2337/db23-0972.
     PubMed     Abstract available
     
     
     
181. SUNILKUMAR S, Dennis MD
     REDD1 is a Promising Therapeutic Target to Combat the Development of Diabetic Complications: A Report on Research Supported by Pathway to Stop Diabetes.
     Diabetes. 2024 Jul 8:dbi240013. doi: 10.2337/dbi24-0013.
     PubMed     Abstract available
     
     
     
182. KJELDSEN SAS, Richter MM, Jensen NJ, Nilsson MSD, et al
     Glucagon resistance in individuals with obesity and hepatic steatosis can be measured using the GLUSENTIC test and index.
     Diabetes. 2024 Jul 8:db230858. doi: 10.2337/db23-0858.
     PubMed     Abstract available
     
     
     
183. JI Z, Lin S, Gui S, Gao J, et al
     Overexpressed Poldip2 incurs retinal fibrosis via the TGFbeta1/SMAD3 signaling pathway in diabetic retinopathy.
     Diabetes. 2024 Jul 5:db231036. doi: 10.2337/db23-1036.
     PubMed     Abstract available
     
     
     
184. YANG Q, Yasvoina M, Olvera-Barrios A, Mendes J, et al
     Deciphering the connection between microvascular damage and neurodegeneration in early diabetic retinopathy.
     Diabetes. 2024 Jul 5:db240107. doi: 10.2337/db24-0107.
     PubMed     Abstract available
     
     
     
185. SCHRODERUS AM, Pitkanen V, Ekman I, Stevens D, et al
     Temporal Alterations in CD8+ T Cells During the Progression from Stage 1 to Stage 3 Type 1 Diabetes.
     Diabetes. 2024 Jul 5:db240159. doi: 10.2337/db24-0159.
     PubMed     Abstract available
     
     
     
186. BREYER MD
     AKR1A1 and Kidney Disease: Promise and Perils of the Multiverse.
     Diabetes. 2024;73:1046-1047.
     PubMed    
     
     
     
187. TAYLOR R
     The Whole Human Pancreas: An Understudied Organ in Diabetes.
     Diabetes. 2024;73:1043-1045.
     PubMed    
     
     
     
188. CORANO SCHERI K, Fawzi AA
     Comment on Hu et al. Single-Cell Transcriptomics Reveals Novel Role of Microglia in Fibrovascular Membrane of Proliferative Diabetic Retinopathy. Diabetes 2022;71:762-773.
     Diabetes. 2024;73:e6-e8.
     PubMed    
     
     
     
189. MAO X, Xu M, Liu Q, Yuan S, et al
     Response to Comment on Hu et al. Single-Cell Transcriptomics Reveals Novel Role of Microglia in Fibrovascular Membrane of Proliferative Diabetic Retinopathy. Diabetes 2022;71:762-773.
     Diabetes. 2024;73:e9-e10.
     PubMed    
     
     
     
190. THORENS B, Hodson DJ
     Building the Glucagon-Like Peptide-1 Receptor Brick by Brick: Revisiting a 1993 Diabetes Classic by Thorens et al.
     Diabetes. 2024;73:1027-1031.
     PubMed     Abstract available
     
     
     
191. WEBBER MJ
     Engineering a Pathway to Glucose-Responsive Therapeutics.
     Diabetes. 2024;73:1032-1038.
     PubMed     Abstract available
     
     
     
192. AGRAWAL S, Luan J, Cummings BB, Weiss EJ, et al
     Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits.
     Diabetes. 2024;73:1099-1111.
     PubMed     Abstract available
     
     
     June 2024
193. D'ALESSIO DA, Kahn SE, Mulder H
     The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal Feature.
     Diabetes. 2024 Jun 24:dbi240034. doi: 10.2337/dbi24-0034.
     PubMed    
     
     
     
194. BYNDLOSS M, Devkota S, Duca F, Hendrik Niess J, et al
     The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications-2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
     Diabetes. 2024 Jun 24:dbi240028. doi: 10.2337/dbi24-0028.
     PubMed     Abstract available
     
     
     
195. KHAN AW, Aziz M, Sourris KC, Lee MK, et al
     The role of activator protein-1 (AP-1) complex in diabetes associated atherosclerosis: Insights from single cell RNA sequencing.
     Diabetes. 2024 Jun 21:db230167. doi: 10.2337/db23-0167.
     PubMed     Abstract available
     
     
     
196. SLOAN G, Teh K, Caunt S, Wilkinson I, et al
     Increased thalamocortical functional connectivity on discontinuation of treatment in painful diabetic peripheral neuropathy.
     Diabetes. 2024 Jun 21:db230931. doi: 10.2337/db23-0931.
     PubMed     Abstract available
     
     
     
197. LESLIE KA, Lekka C, Richardson SJ, Russell MA, et al
     Regulation of STAT1 signalling in human pancreatic beta-cells by the lysine deacetylase, HDAC6; a new therapeutic opportunity in type 1 diabetes?
     Diabetes. 2024 Jun 13:db240008. doi: 10.2337/db24-0008.
     PubMed     Abstract available
     
     
     
198. MAO A, Li Z, Shi X, Zhang K, et al
     Complement factor C1q mediates vascular endothelial dysfunction in STZ-induced diabetic mice.
     Diabetes. 2024 Jun 13:db230981. doi: 10.2337/db23-0981.
     PubMed     Abstract available
     
     
     
199. ZEINI M, Laurenti MC, Egan AM, Muthusamy K, et al
     The longitudinal effect of Diabetes-associated variation in TCF7L2 on islet function in humans.
     Diabetes. 2024 Jun 13:db240192. doi: 10.2337/db24-0192.
     PubMed     Abstract available
     
     
     
200. WOLF SJ, Audu CO, Moon JY, Joshi AD, et al
     Diabetic wound keratinocytes induce macrophage JMJD3-mediated Nlrp3 expression via IL-1R signaling.
     Diabetes. 2024 Jun 13:db230968. doi: 10.2337/db23-0968.
     PubMed     Abstract available
     
     
     
201. FU Q, Song Y, Ling Z, Liu J, et al
     Regulatory Role of NF-kappaB on HDAC2 and Tau Hyperphosphorylation in Diabetic Encephalopathy and the Therapeutic Potential of Luteolin.
     Diabetes. 2024 Jun 13:db230969. doi: 10.2337/db23-0969.
     PubMed     Abstract available
     
     
     
202. LI X, Yuan D, Zhang P, Luo C, et al
     A neural-mast cell axis regulates skin microcirculation in diabetes.
     Diabetes. 2024 Jun 4:db230862. doi: 10.2337/db23-0862.
     PubMed     Abstract available
     
     
     
203. CHEN X, Tripathy D, Chilton R, Hansis-Diarte A, et al
     Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects.
     Diabetes. 2024;73:896-902.
     PubMed     Abstract available
     
     
     
204. PATAKY MW, Nair KS
     Response to Comment on Pataky et al. Divergent Skeletal Muscle Metabolomic Signatures of Different Exercise Training Modes Independently Predict Cardiometabolic Risk Factors. Diabetes 2024;73:23-37.
     Diabetes. 2024;73:e4-e5.
     PubMed    
     
     
     
205. PESCHARD S, Raverdy V, Bauvin P, Goutchtat R, et al
     Genetic Evidence of Causal Relation Between Intestinal Glucose Absorption and Early Postprandial Glucose Response: A Mendelian Randomization Study.
     Diabetes. 2024;73:983-992.
     PubMed     Abstract available
     
     
     
206. JIANG Y, Yang J, Xia L, Wei T, et al
     Gut Microbiota-Tryptophan Metabolism-GLP-1 Axis Participates in beta-Cell Regeneration Induced by Dapagliflozin.
     Diabetes. 2024;73:926-940.
     PubMed     Abstract available
     
     
     May 2024
207. SHILLO P, Sloan G, Selvarajah D, Greig M, et al
     Reduced Thalamic Gamma Aminobutyric Acid (GABA) in Painless but not Painful Diabetic Peripheral Neuropathy.
     Diabetes. 2024 May 22:db230921. doi: 10.2337/db23-0921.
     PubMed     Abstract available
     
     
     
208. LEE CS, Shang R, Wang F, Khayambashi P, et al
     Heparanase Stimulation of Physiological Cardiac Hypertrophy is Suppressed Following Chronic Diabetes Resulting in Cardiac Remodeling and Dysfunction.
     Diabetes. 2024 May 21:db240217. doi: 10.2337/db24-0217.
     PubMed     Abstract available
     
     
     
209. YANG Z, Zhang Z, Li L, Jing Z, et al
     Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-onset Type 1 Diabetes.
     Diabetes. 2024 May 21:db230987. doi: 10.2337/db23-0987.
     PubMed     Abstract available
     
     
     
210. DIAMOND C, Pansini M, Hamid A, Eichert N, et al
     Quantitative imaging reveals steatosis and fibro-inflammation in multiple organs in people with type 2 diabetes: a real-world study.
     Diabetes. 2024 May 14:db230926. doi: 10.2337/db23-0926.
     PubMed     Abstract available
     
     
     
211. FRORUP C, Jensen MH, Haupt-Jorgensen M, Buschard K, et al
     Elevated cathepsin S serum levels in new-onset type 1 diabetes and autoantibody-positive siblings.
     Diabetes. 2024 May 3:db230911. doi: 10.2337/db23-0911.
     PubMed     Abstract available
     
     
     
212. CHOUCAIR I, Mallela DP, Hilser JR, Hartiala JA, et al
     Comprehensive clinical and genetic analyses of circulating bile acids and their associations with diabetes and its indices.
     Diabetes. 2024 May 3:db230676. doi: 10.2337/db23-0676.
     PubMed     Abstract available
     
     
     
213. SHEN KC, Collins KH, Ferey JLA, Fappi A, et al
     Excess Intramyocellular Lipid Does Not Affect Muscle Fiber Biophysical Properties in Mice or People with Metabolically Abnormal Obesity.
     Diabetes. 2024 May 3:db230991. doi: 10.2337/db23-0991.
     PubMed     Abstract available
     
     
     
214. GUPTA OT, Gupta RK
     The Expanding Problem of Regional Adiposity: Revisiting a 1985 Diabetes Classic by Ohlson et al.
     Diabetes. 2024;73:649-652.
     PubMed     Abstract available
     
     
     
215. AMANDA DK
     A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology. Diabetes 2023;72:812-818.
     Diabetes. 2024;73:e1-e2.
     PubMed    
     
     
     April 2024
216. LEE HJ, Min L, Gao J, Matta S, et al
     Female protection against diabetic kidney disease is regulated by kidney-specific AMPK activity.
     Diabetes. 2024 Apr 24:db230807. doi: 10.2337/db23-0807.
     PubMed     Abstract available
     
     
     
217. LIU J, Aylor KW, Liu Z
     Erratum. Liraglutide and Exercise Synergistically Attenuate Vascular Inflammation and Enhance Metabolic Insulin Action in Early Diet-Induced Obesity. Diabetes 2023;72:918-931.
     Diabetes. 2024 Apr 23:db24er07a. doi: 10.2337.
     PubMed     Abstract available
     
     
     
218. YAMATO M, Kato N, Yamada KI, Inoguchi T, et al
     The Early Pathogenesis of Diabetic Retinopathy and Its Attenuation by Sodium-Glucose Transporter 2 Inhibitors.
     Diabetes. 2024 Apr 12:db220970. doi: 10.2337/db22-0970.
     PubMed     Abstract available
     
     
     
219. LI Y, Chen GC, Moon JY, Arthur R, et al
     Genetic subtypes of prediabetes, healthy lifestyle, and risk of type 2 diabetes.
     Diabetes. 2024 Apr 11:db230699. doi: 10.2337/db23-0699.
     PubMed     Abstract available
     
     
     
220. ASTRADA A
     Comment on Pataky et al. Divergent Skeletal Muscle Metabolomic Signatures of Different Exercise Training Modes Independently Predict Cardiometabolic Risk Factors. Diabetes 2024;73:23-37.
     Diabetes. 2024 Apr 9:db240033. doi: 10.2337/db24-0033.
     PubMed    
     
     
     
221. PURNELL JQ
     Metabolic-Bariatric Surgery for Type 2 Diabetes: Time(ing) for a Change.
     Diabetes. 2024;73:542-544.
     PubMed    
     
     
     
222. EVANS-MOLINA C
     The Ailing beta-Cell in Diabetes: Insights From a Trip to the ER: The 2023 Outstanding Scientific Achievement Award Lecture.
     Diabetes. 2024;73:545-553.
     PubMed     Abstract available
     
     
     
223. DRAWSHY Z, Neiman D, Fridlich O, Peretz A, et al
     DNA Methylation-Based Assessment of Cell Composition in Human Pancreas and Islets.
     Diabetes. 2024;73:554-564.
     PubMed     Abstract available
     
     
     
224. SLAK RUPNIK M, Hara M
     Local Dialogues Between the Endocrine and Exocrine Cells in the Pancreas.
     Diabetes. 2024;73:533-541.
     PubMed     Abstract available
     
     
     
225. SCHWEITZER N, Son SJ, Aizenstein H, Yang S, et al
     Higher HbA1c Is Associated With Greater 2-Year Progression of White Matter Hyperintensities.
     Diabetes. 2024;73:604-610.
     PubMed     Abstract available
     
     
     
226. DEVKOTA R, Small JC, Carbone K, Glass MA, et al
     KD025 Is a Casein Kinase 2 Inhibitor That Protects Against Glucolipotoxicity in beta-Cells.
     Diabetes. 2024;73:585-591.
     PubMed     Abstract available
     
     
     March 2024
227. RAMOS SV, Distefano G, Lui LY, Cawthon PM, et al
     Role of Cardiorespiratory Fitness and Mitochondrial Oxidative Capacity in Reduced Walk Speed of Older Adults with Diabetes.
     Diabetes. 2024 Mar 29:db230827. doi: 10.2337/db23-0827.
     PubMed     Abstract available
     
     
     
228. ABRAHAM A, Cule M, Thanaj M, Basty N, et al
     Genetic evidence for distinct biological mechanisms that link adiposity to type 2 diabetes: towards precision medicine.
     Diabetes. 2024 Mar 26:db231005. doi: 10.2337/db23-1005.
     PubMed     Abstract available
     
     
     
229. WILLIAMS RC, Hanson RL, Peters B, Kearns K, et al
     Epistasis Between HLA-DRB1*16:02:01 and SLC16A11 T-C-G-T-T Reduces Odds for Type 2 Diabetes in Southwest American Indians.
     Diabetes. 2024 Mar 26:db230925. doi: 10.2337/db23-0925.
     PubMed     Abstract available
     
     
     
230. FAWAZ S, Martin Alonso A, Qiu Y, Ramnath R, et al
     Adiponectin reduces glomerular endothelial glycocalyx disruption and restores glomerular barrier function in a mouse model of type 2 diabetes.
     Diabetes. 2024 Mar 26:db230455. doi: 10.2337/db23-0455.
     PubMed     Abstract available
     
     
     
231. FAN Y, Chow E, Lim CKP, Hou Y, et al
     Comparison of beta-cell function and insulin sensitivity between normal-weight and obese Chinese with young-onset type 2 diabetes.
     Diabetes. 2024 Mar 20:db230966. doi: 10.2337/db23-0966.
     PubMed     Abstract available
     
     
     
232. XIE Y, Yuan Q, Tang B, Xie Y, et al
     CPT1A Protects Podocytes from Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo.
     Diabetes. 2024 Mar 20:db230811. doi: 10.2337/db23-0811.
     PubMed     Abstract available
     
     
     
233. PEDERSEN FN, Stokholm L, Andersen N, Andresen J, et al
     Risk of diabetic retinopathy according to subtype of type 2 diabetes.
     Diabetes. 2024 Mar 18:db240016. doi: 10.2337/db24-0016.
     PubMed     Abstract available
     
     
     
234. IRVIN MR, Ge T, Patki A, Srinivasasainagendra V, et al
     Polygenic Risk for Type 2 Diabetes in African Americans.
     Diabetes. 2024 Mar 12:db230232. doi: 10.2337/db23-0232.
     PubMed     Abstract available
     
     
     February 2024
235. LI D, Hsu FC, Palmer ND, Liu L, et al
     Multi-omics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease.
     Diabetes. 2024 Feb 23:db230540. doi: 10.2337/db23-0540.
     PubMed     Abstract available
     
     
     
236. HAN X, Wei J, Zheng R, Tu Y, et al
     Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-kB-Dependent Inflammation.
     Diabetes. 2024 Feb 23:db230700. doi: 10.2337/db23-0700.
     PubMed     Abstract available
     
     
     January 2024
237. WYATT RC, Grace SL, Brigatti C, Marzinotto I, et al
     Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system (LIPS) assays.
     Diabetes. 2024 Jan 17:db230550. doi: 10.2337/db23-0550.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.